Analyst Ratings for Oncternal Therapeutics (ONCT)
ONCT Rating Summary
ONCT Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.00 (+74.4%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
Avg. $ Target:
$15.00 (+74.4%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/4/2023 | Brookline Capital Markets | Kemp Dolliver | Upgrade | Buy (Hold) |
2.00 (N/A) |
0.34 (8.60) |
2429.41% | Details |
| 9/18/2023 | H.C. Wainwright » Updated 4/15/2024 |
Raghuram Selvaraju | Upgrade | Buy (Neutral) |
28.00 (30.00) |
0.35 (8.60) |
2357.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
